Report in The Journal of Molecular Diagnostics describes a more sensitive and personalized method of identifying patients likely to relapse compared to the current gold standard.
New assay detects persistent disease in leukemia patients thought to be in remission
No replies to this topic
1 user(s) are reading this topic
0 members, 1 guests, 0 anonymous users